Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Post-Herniorrhaphy Non-opioid MMA Regimens

ClinicalTrials.gov ID: NCT03907176

Public ClinicalTrials.gov record NCT03907176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Randomized, Open-Label Study of HTX-011 as the Foundation of a Non-opioid, Multimodal Analgesic Regimen to Decrease Opioid Use Following Unilateral Open Inguinal Herniorrhaphy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference for MMA regimen.

Study identification

NCT ID
NCT03907176
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Heron Therapeutics
Industry
Enrollment
209 participants

Conditions and interventions

Conditions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 4, 2019 (Actual)
Primary completion
Oct 25, 2021 (Actual)
Completion
Nov 22, 2021 (Actual)
Last update posted
Jun 4, 2026

2019 – 2021

United States locations

U.S. sites
30
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801 —
Horizon Clinical Research La Mesa California 91942 —
Sharp Grossmont Hospital La Mesa California 91942 —
University of California, Irvine Medical Center Orange California 92868 —
Parkview Community Hospital Riverside California 92503 —
Yale University School of Medicine New Haven Connecticut 06510 —
Medical Research of Westchester, Inc Miami Florida 33144 —
Professional Health Care of Pinellas St. Petersburg Florida 33713 —
University of Louisville Hospital Louisville Kentucky 40202 —
Baylor University Medical Center Dallas Missouri 75246 —
Washington University School of Medicine St Louis Missouri 63110 —
Rutgers - New Jersey Medical School Newark New Jersey 07103 —
Stony Brook University Hospital Stony Brook New York 11794 —
Montefiore Hutchinson Campus The Bronx New York 10461 —
M3 Emerging Medical Research, LLC Durham North Carolina 27704 —
Cleveland Clinic Fairview Cleveland Ohio 44111 —
Cleveland Clinic Cleveland Ohio 44195 —
The Ohio State University Wexner Medical Center - University Hospital Columbus Ohio 43210 —
Midwest Clinical Research Center, LLC Dayton Ohio 45417 —
Summit Medical Group Oregon-Bend Memorial Clinic Bend Oregon 97701 —
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
UPMC Shadyside Hospital Pittsburgh Pennsylvania 15232 —
UPMC Passavant Pittsburgh Pennsylvania 15237 —
Baylor University Medical Center Dallas Texas 75246 —
Hermann Drive Surgical Hospital Houston Texas 77004 —
Houston Methodist Hospital Houston Texas 77030 —
Plano Surgical Hospital Plano Texas 75093 —
Endeavor Clinical Trials, LLC San Antonio Texas 78229 —
JBR Clinical Research Draper Utah 84020 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03907176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03907176 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →